Loading…
Premier Manufacturing Products, LLC received an FDA Warning Letter on June 12, 2024, regarding violations related to drug manufacturing or distribution. Based on the limited metadata available, the letter identifies two specific compliance violations, though the exact nature of these violations cannot be determined without access to the full letter text. The warning falls under FDA's drug product oversight, though the specific issuing office is not identified in the available metadata. To understand the precise regulatory concerns and required corrective actions, the complete Warning Letter would need to be reviewed.